BeStock  
Markets › Compare › HAE vs GMED

HAE vs GMED

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
HAE · Haemonetics$120.16 ▼ 0.17%
GMED · Globus Medical$66.89 ▼ 2.49%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

6086113139166Nov 24, '25May 26, '26Nov 20, '26
  • HAE +50.9%
  • GMED -23.9%

Head to head

MetricHAEGMED
Price$120.16$66.89
Change today▼ 0.17%▼ 2.49%
Market cap$5.47B$8.86B
Return, 3 months+10.8%-20.4%
Return, year to date+49.9%-23.4%
Return, 1 year+52.5%-22.2%
P/E (TTM)53.216.5
P/B6.11.8
P/E percentile vs own 5y78th1st
Dividend yield––
Revenue growth (YoY, latest qtr)+9.3%-0.7%
Net profit growth (YoY)+19.7%+18.7%
Gross margin59.6%69.1%
Operating margin18.3%22.8%
Net margin7.5%17.8%
Return on equity11.9%12.1%
Analyst target vs. price+21.3%+39.4%
Analyst buy share80%70%
RSI (14)5235
30-day volatility30.2%66.2%
Max drawdown, 1 year-40.1%-30.9%
Trend readLeaning bullishStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • GMED is the largest of the group by market value.
  • HAE has returned the most over the past year.
  • GMED carries the lowest trailing P/E.
  • HAE is growing revenue fastest.
  • GMED keeps the most profit per dollar of sales.
  • HAE has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top